Drug intelligence / Profile preview

TFX1

Development stage
Preclinical
Modality
Peptides
Administration
Intravenous, Topical, Oral, Intramuscular
01

Overview

TFX1 is a selective, ribosomally-synthesized, post-translationally modified peptide antibiotic, produced by the bacterium *Rhizobium leguminosarum bv. trifolii T24*. It is one of two geometric isomers of Trifolitoxin (TFX), derived from an inactive primary amino acid sequence. TFX1 specifically inhibits α-proteobacteria, including plant symbionts like *Rhizobium spp.*, plant pathogens such as *Agrobacterium spp.*, and animal pathogens like *Brucella abortus*. Its biological activity is dependent on post-translational modifications, which include the formation of a thiazoline ring from Gly-Cys and a blue fluorescent chromophore from a modified Arg-Gln-Gly sequence. TFX2, another isomer, has been found to be significantly more active than TFX1.

Other names
Trifolitoxin

Beyond the preview

Go deeper on TFX1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TFX1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call